Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer

被引：0

作者：

Kelly, R. ^{[1
]}

Wong, S. S. L. ^{[2
]}

Shapiro, J. ^{[3
]}

Weickhardt, A. J. ^{[4
]}

Parente, P. ^{[5
]}

Azad, A. ^{[6
]}

Uccellini, A. ^{[7
]}

Torres, J. ^{[8
]}

Parnis, F. ^{[9
]}

Kwan, E. ^{[10
]}

Brown, S. ^{[11
]}

Steer, C. ^{[12
]}

Warren, M. ^{[13
]}

Gibbs, P. ^{[14
]}

Anton, A. ^{[1
]}

Tran, B. ^{[1
]}

机构：

[1] Walter Eliza Hall Inst Med Res, Clin Data Clin Trials & Biomarkers, Parkville, Vic, Australia

[2] Sunshine Hosp Western Hlth, Med Affairs Dept, St Albans, Vic, Australia

[3] Alfred Hosp, Med Oncol, Melbourne, Vic, Australia

[4] Olivia Newton John Canc Wellness & Res Ctr, Dept Med Oncol, Heidelberg, Vic, Australia

[5] Box Hill Hosp, Eastern Hlth, Dept Med Oncol, Bldg B, Box Hill, Vic, Australia

[6] Peter MacCallum Canc Ctr, Dept Oncol, Melbourne, Vic, Australia

[7] Austin Hosp, Austin Hlth, Med Oncol, Heidelberg, Vic, Australia

[8] Goulburn Valley Hlth, Dept Med Oncol, Shepparton, Vic, Australia

[9] Adelaide Canc Ctr, Dept Med Oncol, Adelaide, SA, Australia

[10] Monash Canc Ctr, Monash Hlth, Med Oncol, Bentleigh East, Vic, Australia

[11] Ballarat Hlth Serv, Med Oncol, Ballarat Base Hosp, Ballarat, Vic, Australia

[12] Border Med Oncol, Dept Med Oncol, East Albury, Vic, Australia

[13] Bendigo Hlth, Med Oncol, Bendigo, Vic, Australia

[14] WEHI Walter & Eliza Hall Inst Med Res, Dept Oncol, Parkville, Vic, Australia

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.10.202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

165P

引用

页码：S1498 / S1499

页数：2

共 50 条

[1] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Sweeney, Christopher J.
Chen, Yu-Hui
Carducci, Michael
Liu, Glenn
Jarrard, David F.
Eisenberger, Mario
Wong, Yu-Ning
Hahn, Noah
Kohli, Manish
Cooney, Matthew M.
Dreicer, Robert
Vogelzang, Nicholas J.
Picus, Joel
Shevrin, Daniel
Hussain, Maha
Garcia, Jorge A.
DiPaola, Robert S.
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 737 - 746
[2] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Mathieu, Romain
Shariat, Shahrokh F.
EUROPEAN UROLOGY, 2016, 69 (04) : 755 - 756
[3] Re: Chemohormonal Therapy in Metastatic Hormone-sensitive Prostate Cancer
de Reijke, Theo
EUROPEAN UROLOGY, 2016, 69 (01) : 178 - 178
[4] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Murphy, Declan G.
Zargar, Homayoun
EUROPEAN UROLOGY, 2016, 69 (03) : 540 - 540
[5] Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Azad, Arun A.
Tran, Ben
Davis, Ian D.
Parente, Phillip
Evans, Melanie
Wong, Shirley
Brown, Stephen
Evans, Sue
Millar, Jeremy
Murphy, Declan G.
Papa, Nathan
INTERNAL MEDICINE JOURNAL, 2022, 52 (08) : 1339 - 1346
[6] Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
Ciccarese, Chiara
Santoni, Matteo
Massari, Francesco
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 286 - 286
[7] Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective
Teoh, Jeremy Yuen-Chun
Ng, Chi-Fai
Poon, Darren Ming-Chun
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 5 - 8
[8] Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer
Sathianathen, Niranjan J.
Philippou, Yiannis A.
Kuntz, Gretchen M.
Konety, Badrinath R.
Gupta, Shilpa
Lamb, Alastair D.
Dahm, Philipp
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
[9] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Editorial Comment
Taneja, Samir S.
JOURNAL OF UROLOGY, 2016, 195 (01): : 94 - 94
[10] Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A Review
Kyriakopoulos, Christos E.
Liu, Glenn
CANCER JOURNAL, 2016, 22 (05): : 322 - 325

← 1 2 3 4 5 →